«Papillomavirus Infections

Below is an extended Papillomavirus Infections patents listing. Click here to return to the Papillomavirus Infections main in depth entry.

Patents :
US Patent No.	Title
6908613	Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
7101560	Combination vaccine for administration to adolescents
7169585	Papillomavirus vaccine
7172870	Treatment of papillomavirus infections
7175849	Nectin polypeptides
7182947	Papillomavirus truncated L1 protein and fusion protein constructs
7186700	.beta.-L-2'-deoxynucleosides for the treatment of resistant HBV strains and combination therapies
7186802	Claudin polypeptides
7202034	Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
7211569	Synthetic human papilloma virus genes
7220419	Self-assembling recombinant papillomavirus capsid proteins
7087228	Preventing tooth decay and infective endocarditis using natural oligopeptides
7056896	Carbohydrate or 2'-modified oligonucleotides having alternating internucleoside linkages
6908615	DNA encoding human papilloma virus type 18
6926897	Medicament for the avoidance or treatment of papillomavirus-specific tumour
6927032	Expression monitoring by hybridization to high density oligonucleotide arrays
6933123	Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers
6936255	Vaccine composition comprising herpes simplex virus and human papilloma virus antigens
6946256	Cell regulatory genes, encoded products, and uses related thereto
6962777	IN VITRO METHOD FOR DISASSEMBLY/REASSEMBLY OF PAPILLOMAVIRUS VIRUS-LIKE PARTICLES (VLPS), HOMOGENEOUS VLP AND CAPSOMERE COMPOSITIONS PRODUCED BY SAID METHODS; USE THEREOF AS VEHICLE FOR IMPROVED PURIFICATION, AND DELIVERY OF ACTIVE AGENTS
6969585	Universal collection medium
7001995	Synthetic human papillomavirus genes
7030227	Cell regulatory genes, encoded products, and uses related thereto
7220551	Composition
7223556	Targeted proteolysis by recruitment to ubiquitin protein ligases
7351533	In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents
7354908	Materials and methods for prevention and treatment of RNA viral diseases
7355034	Oligonucleotides for use in determining the presence of human papilloma virus in a test sample
7361356	Self-assembling recombinant papillomavirus capsid proteins
7361752	RNAi modulation of MLL-AF4 and uses thereof
7371390	Vaccine against HBV and HPV
7371391	Papilloma virus capsomere vaccine formulations and methods of use
7371518	Universal collection medium
7390487	Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
7396905	Calcipressins: endogenous inhibitors of calcineurin, uses and reagents related thereto
7335765	Nucleoside and oligonucleotide analogues
7332478	Antitumoral composition based on immunogenic polypeptide with modified cell location
7235244	Compositions and methods for treating papillomavirus-infected cells
7247433	Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles
7267961	Peptides from the E7 protein of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papilloma virus associated cancers
7276477	Crystals of etanercept and methods of making thereof
7279306	Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof
7285386	RhPV as a model for HPV-induced cancers
7291455	Assessment of human papilloma virus-related disease
7294459	Cell regulatory genes, encoded products, and uses related thereto
7314923	Nucleoside and oligonucleotide analogues
7316908	Peptides from the E2 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers
7423138	Compositions and methods for treating papillomavirus-infected cells

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.